Published: May 20th 2025 | Updated: June 4th 2025
Myeloma Research Sees Transformation Following ODAC Support For MRD End Point
Published: May 19th 2025 | Updated: May 20th 2025
One Year After ODAC Decision: Myeloma Studies Move to Adopt MRD End Point
Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: January 6th 2023 | Updated: June 14th 2025
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: June 10th 2025 | Updated: June 14th 2025
Advancing Head and Neck Cancer Treatment: Insights From KEYNOTE-689